Actio Biosciences Overview
- Year Founded
-
2021
- Status
-
Acquired/Merged
- Employees
-
45
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$820M
Actio Biosciences General Information
Description
Developer of genetics-driven precision medicines designed to treat rare diseases and expand into prevalent diseases with shared underlying biology. The company's therapeutics comprise orally administered small-molecule modulators identified through human genetics, advanced informatics, and disease-model research, enabling patients with genetically defined diseases to receive treatments targeting the underlying biological mechanisms of their conditions.
Contact Information
Website
www.actiobiosciences.com(Operating Subsidiary)
Corporate Office
- 11202 El Camino Real
- Suite 100
- San Diego, CA 92130
- United States
Corporate Office
- 11202 El Camino Real
- Suite 100
- San Diego, CA 92130
- United States
Actio Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 15-Sep-2026 | $820M | Completed | Clinical Trials - Phase 1 | ||
| 2. Early Stage VC (Series B) | 18-Jun-2025 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC (Series A1) | 12-Sep-2023 | $55M | $55M | Completed | Pre-Clinical Trials |
Actio Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-1 |
Actio Biosciences Comparisons
Industry
Financing
Details
Actio Biosciences Competitors (3)
One of Actio Biosciences’s 3 competitors is Encoded, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Encoded | Venture Capital-Backed | South San Francisco, CA | ||||
| AskBio | Formerly VC-backed | Durham, NC | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
Actio Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Actio Biosciences Patents
Actio Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231583-A1 | Synthetic intermediates and methods | Pending | 28-Apr-2025 | ||
| WO-2026231585-A1 | Therapeutic macrocycles | Pending | 28-Apr-2025 | ||
| WO-2026231584-A1 | Trpv4 inhibitor compounds and medical uses thereof | Pending | 28-Apr-2025 | ||
| WO-2025255170-A1 | Heterocyclic compounds useful as kcnt1 inhibitors | Pending | 03-Jun-2024 | ||
| AU-2024390752-A1 | Heterocyclic compounds useful as kcnt1 inhibitors | Pending | 29-Nov-2023 | C07D401/14 |
Actio Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Actio Biosciences Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canaan Partners | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| Droia Ventures | Venture Capital | Minority | ||
| EcoR1 Capital | Venture Capital | Minority | ||
| Euclidean Capital | Family Office | Minority |
Actio Biosciences FAQs
-
When was Actio Biosciences founded?
Actio Biosciences was founded in 2021.
-
Where is Actio Biosciences headquartered?
Actio Biosciences is headquartered in San Diego, CA.
-
What is the size of Actio Biosciences?
Actio Biosciences has 45 total employees.
-
What industry is Actio Biosciences in?
Actio Biosciences’s primary industry is Drug Discovery.
-
Is Actio Biosciences a private or public company?
Actio Biosciences is a Private company.
-
What is the current valuation of Actio Biosciences?
The current valuation of Actio Biosciences is .
-
What is Actio Biosciences’s current revenue?
The current revenue for Actio Biosciences is .
-
How much funding has Actio Biosciences raised over time?
Actio Biosciences has raised $121M.
-
Who are Actio Biosciences’s investors?
Canaan Partners, Deerfield Management, Droia Ventures, EcoR1 Capital, and Euclidean Capital are 5 of 7 investors who have invested in Actio Biosciences.
-
Who are Actio Biosciences’s competitors?
Encoded, AskBio, and Genetix Biotherapeutics are competitors of Actio Biosciences.
-
When was Actio Biosciences acquired?
Actio Biosciences was acquired on 15-Sep-2026.
-
Who acquired Actio Biosciences?
Actio Biosciences was acquired by Jazz Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
